Trial Profile
A retrospective study of mepolizumab treatment for severe eosinophilic asthma: real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2018
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Nov 2018 New trial record
- 19 Sep 2018 Results assessing glucocorticosteroid effects of mepolizumab in patients with severe asthma, presented at the 28th Annual Congress of the European Respiratory Society.